First publication for ResistancePlus MG

Announcing the first publication for our ResistancePlus® MG assay, published in PLOS ONE in collaboration with Sepehr Tabrizi, PhD at the Royal Women’s Hospital in Melbourne, Australia.

“The SpeeDx assay provides valuable information to the clinicians in a rapid time frame allowing for better treatment of patients infected with M. genitalium,” says Dr. Tabrizi. “We believe this study is a positive first step in combating the growing problem of antibiotic resistance in M. genitalium.”

Read the press release here

Read the PLOS ONE article here